论文部分内容阅读
目的探讨临床药师在经皮冠状动脉介入术后个体化抗血小板治疗中的作用。方法回顾临床药师依据基因检测参与1例经皮冠状动脉介入术后支架内血栓形成的抗血小板治疗的案例。结果临床药师依据基因检测分析经皮冠状动脉介入术后支架内血栓形成的原因,参与抗血小板治疗方案的调整,并对患者提供药学监护和用药教育,保证患者用药安全、有效。结论临床药师依据基因检测参与临床治疗方案的制订和调整,为实施个体化用药提供依据,可作为临床药师药学服务的切入点。
Objective To explore the role of clinical pharmacists in the treatment of personalized antiplatelet after percutaneous coronary intervention. Methods A retrospective clinical pharmacist was involved in the antiplatelet therapy of thrombosis in a stent following percutaneous coronary intervention based on genetic testing. Results Clinical pharmacists analyzed the causes of stent thrombosis after percutaneous coronary intervention on the basis of genetic tests and were involved in the adjustment of antiplatelet regimens. They also provided medical education and medication education to patients to ensure the safety and effectiveness of medication. Conclusion Clinical pharmacists are involved in the formulation and adjustment of clinical treatment programs based on genetic testing, providing a basis for individualized drug use and serving as an entry point for clinical pharmacist pharmacy services.